• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Do Antidepressants Cause Switching?

Do Antidepressants Cause Switching?

August 1, 2006
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
The latest foray into the controversial issue of antidepressant-induced switching appeared in the February issue of The American Journal of Psychiatry (2006;163:232-239).

The last time TCPR took up this topic (June 2005), we reviewed a meta-analysis of antidepressant use in bipolar disorder. That paper concluded that SSRIs cause the same rate of manic switching as placebo (Am J Psychiatry 2004;161:1537-1547). The authors of the newly published research would beg to differ.

In this study, 159 patients with bipolar depression (all of whom were taking mood stabilizers) were randomized in a double-blind protocol to receive adjunctive treatment with Wellbutrin (bupropion, mean dose, 286 mg/day), Zoloft (sertraline, 192 mg/day), or Effexor (venlafaxine, 195 mg/day). The patients were followed for 10 weeks, though some entered into a continuation treatment arm that went on for up to a year. Overall, 48.7% of patients responded within 10 weeks, and there were no significant differences in response rate between the different ADs.

The focus of the paper, however, was not on treatment response, but rather on whether these medications caused manic switching. The authors reported the overall rate of hypomania or mania as 19.3% within the first 10 wks and 36.8% within a year.

The three agents did not differ significantly in switch risk. Inexplicably, however, the authors created a novel statistical measure that made it appear as though there were differences. They defined two different types of switches: “threshold” switches (what we normally think of when we think of manic switches) and “subthreshold” switches (meaning a switch to a hypomanic state that was too brief to be diagnosable). Their new statistic is the ratio of “threshold switches to subthreshold hypomanias.” If you find yourself scratching your head and wondering why this ratio is useful, welcome to the club!

Nonetheless, when this ratio was used to compare the ADs, Effexor had by far the highest ratio, and Wellbutrin the lowest. According to the authors, this result fits into the theory that dual reuptake agents, like the tricyclic desipramine, are more dangerous to give in bipolar depression than either SSRIs or Wellbutrin. Before you conclude that something nefarious is afoot here, note that this research was funded by both the non-profit Stanley Foundation and the NIMH. And most of the authors have independent financial relationships with an array of drug companies, suggesting that they weren’t biased toward any particular product.

What do we make of these findings? It’s clear from these findings that bipolar patients frequently become manic or hypomanic. However, since there was no placebo group in this study, we don’t know whether these switches simply reflect the natural course of bipolar disorder or whether they reflect the specific action of antidepressants.

Although the authors concluded that “venlafaxine was associated with the highest relative risk of switching and bupropion with the lowest risk,” the actual switch rates do not seem to support this conclusion.

TCPR Verdict:
Manic switching: The answer still eludes us.
General Psychiatry
KEYWORDS antidepressants
www.thecarlatreport.com
Issue Date: August 1, 2006
SUBSCRIBE NOW
Table Of Contents
Bipolar Disorder in Children: Is the Diagnosis Valid?
The STEP-BD Study: An Introduction
Do Antidepressants Cause Switching?
Bipolar II Disorder: A Useful Concept?
Understanding the STEP-BD Study
CATIE, STAR*D, STEP-BD
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.